MALAKAPOGU RAVINDRA BABU

Dr. MALAKAPOGU RAVINDRA BABU


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VHVancha Harish
Vancha Harish
DTDevesh Tewari
Devesh Tewari
SMSHARFUDDIN MOHD
SHARFUDDIN MOHD
PGPilli Govindaiah
Pilli Govindaiah
MBMALAKAPOGU RAVINDRA BABU
MALAKAPOGU RAVINDRA BABU
SSSACHIN Kumar SINGH
SACHIN Kumar SINGH
Many natural products with greater therapeutic efficacy are limited to target several chronic diseases such as cancer, diabetes, and neurodegenerative diseases. Among the natural products from hops, i.e., Xanthohumol (XH), is a prenylated chalcone. The present research work focuses on the enhancement of the poor oral bioavailability and weak pharmacokinetic profile of XH. We exemplified the development of a Xanthohumol-loaded solid lipid nanoparticles (XH-SLNs) cargo system to overcome the limitations associated with its bioavailability. The XH-SLNs were prepared by a high-shear homogenization/ultrasonication method and graphical, numerical optimization was performed by using Box–Behnken Design. Optimized XH-SLNs showed PS (108.60 nm), PDI (0.22), ZP (−12.70 mV), %EE (80.20%) and an amorphous nature that was confirmed by DSC and PXRD. FE-SEM and HRTEM revealed the spherical morphology of XH-SLNs. The results of release studies were found to be 9.40% in 12 h for naive XH, whereas only 28.42% of XH was released from XH-SLNs. The slow release of drugs may be due to immobilization of XH in the lipid matrix. In vivo pharmacokinetic study was performed for the developed XH-SLNs to verify the enhancement in the bioavailability of XH than naive XH. The enhancement in the bioavailability of the XH was confirmed from an increase in Cmax (1.07-folds), AUC0-t (4.70-folds), t1/2 (6.47-folds) and MRT (6.13-folds) after loading into SLNs. The relative bioavailability of XH loaded in SLNs and naive XH was found to be 4791% and 20.80%, respectively. The cytotoxicity study of naive XH, XH-SLNs were performed using PC-3 cell lines by taking camptothecin as positive control. The results of cytotoxicity study revealed that XH-SLNs showed good cell inhibition in a sustained pattern. This work successfully demonstrated formulation of XH-SLNs with sustained release profile and improved oral bioavailability of XH with good anticancer properties against PC-3 cells.

10 May 2025 in New Microbes and New Infections
Verified
Journal Article
Open access
Shriyansh SrivastavaShriyansh Srivastava
Shriyansh Srivastava
Ranjit SahRanjit Sah
Ranjit Sah
MBMALAKAPOGU RAVINDRA BABU
MALAKAPOGU RAVINDRA BABU
DSDeepika Sharma
Deepika Sharma
Dheeraj SharmaDheeraj Sharma
Dheeraj Sharma
Alfonso J. Rodriguez-MoralesAlfonso J. Rodriguez-Morales
Alfonso J. Rodriguez-Morales
Oropouche fever, caused by the Oropouche virus (OROV), has become a significant public health concern. Recent outbreaks highlight its increasing global spread, driven by environmental, social, and ecological factors. The disease presents clinical similarities to other arboviral infections, making accurate diagnosis essential for effective management and prevention. This article examines the epidemiological patterns of Oropouche fever, including its geographic distribution and outbreak drivers. It explores the clinical manifestations of the disease, focusing on common symptoms, complications such as fatal cases and fetal abnormalities, and the necessity of differential diagnosis. The pathophysiology of OROV infection is analyzed, detailing viral entry mechanisms, immune responses, and the role of vectors in transmission. Additionally, we assess diagnostic challenges, comparing serological and molecular methods while identifying their limitations. Therapeutic strategies are also reviewed, including symptomatic treatments and potential antiviral candidates. Findings indicate that OROV infections mimic other arboviral diseases, complicating clinical diagnosis. Current diagnostic tools have limitations in accuracy and accessibility, particularly in resource-limited settings. Symptomatic treatment remains the primary approach, as no specific antiviral therapies or vaccines exist. The study identifies gaps in diagnostic development, vaccine research, and public health surveillance. Oropouche fever threatens global health, necessitating improved surveillance, diagnostic tools, and targeted research efforts. Enhancing epidemiological studies and developing effective vaccines will mitigate its impact. Strengthening public health strategies can help control the spread of OROV and reduce its burden on affected populations.

7 November 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MCMVNL Chaitanya
MVNL Chaitanya
ARArya Kadukkattil Ramanunny
Arya Kadukkattil Ramanunny
MBMALAKAPOGU RAVINDRA BABU
MALAKAPOGU RAVINDRA BABU
DGDr. Monica Gulati
Dr. Monica Gulati
SVSukriti Vishwas
Sukriti Vishwas
SSSACHIN Kumar SINGH
SACHIN Kumar SINGH
Rosmarinic acid (RA) is a polyphenolic metabolite found in various culinary, dietary sources, and medicinal plants like Coleus scutellarioides (Linn) Benth., Lavandula angustifolia Linn., Mellisa officinalis Linn., Origanum vulgare Linn., Rosmarinus officinalis Linn., Zataria multiflora Boiss. and Zhumeria majdae Rech. F. Apart from its dietary and therapeutic values, RA is an important anticancer phytochemical owing to its multi-targeting anticancer mechanism. These properties provide a scope for RA’s therapeutic uses beyond its traditional use as a dietary source. However, its oral bioavailability is limited due to its poor solubility and permeability. This impedes its efficacy in treating cancer. Indeed, in recent years, tremendous efforts have been put towards the development of nanoformulations of RA for treating cancer. However, this research is in its initial stage as bringing a nanoparticle into the market itself is associated with many issues such as stability, toxicity, and scale-up issues. Considering these pitfalls during formulation development and overcoming them would surely provide a new face to RA as a nanomedicine to treat cancer. A literature search was conducted to systematically review the various biological sources, extraction techniques, and anticancer mechanisms through which RA showed multiple therapeutic effects. Various nanocarriers of RA pertaining to its anticancer activity are also discussed in this review.

30 May 2025 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
DSDeepika Sharma
Deepika Sharma
SSShriyansh Srivastava
Shriyansh Srivastava
MBMALAKAPOGU RAVINDRA BABU
MALAKAPOGU RAVINDRA BABU

14 April 2019 in International Journal of Research in Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
MBMALAKAPOGU RAVINDRA BABU
MALAKAPOGU RAVINDRA BABU
RPRavi Prakash P
Ravi Prakash P
DNDevanna N
Devanna N
The purpose of the present study was to formulate Solid Lipid Nanoparticles (SLNs) of Ganciclovir (GCV) in combination with Chitosan and Piperine for absorption enhancement effect. GCV loaded SLNs were prepared by hot homogenization method, optimized and characterized. Formulated SLNs were incorporated with absorption enhancers and characterized for invitro absorption (with chicken intestine), histopathological and invivo pharmacokinetic studies. Invitro absorption studies revealed that the permeability coefficient of the prepared formulation is more when compared to the pure drug, so the permeability is more for prepared formulation. In vivo pharmacokinetic study showed a significant increase in the Cmax, AUC, biological half-life and decrease in elimination rate constant for prepared formulation compared to pure drug. Histopathological studies also showed mild reversible damage of epithelial cells with Chitosan which indicates the safety and efficacy of the formulation. Thus, GCV loaded SLNs prepared with Chitosan can be clinically promising for enhancing the oral, intestinal absorption of the said BCS Class-III drug.

21 April 2026 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
DSDeepika Sharma
Deepika Sharma
MBMALAKAPOGU RAVINDRA BABU
MALAKAPOGU RAVINDRA BABU
SSShriyansh Srivastava
Shriyansh Srivastava
IntroductionCancer continues to pose a serious global health challenge, contributing significantly to morbidity and mortality across diverse populations [1]. The disease arises from complex genetic...